Ashkan Lashkari MD
Cancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer
Physician at Wellness Oncology and Hematology
Join to View Full Profile
7320 Woodlake AveSuite 330West Hills, CA 91307
Phone+1 818-346-1773
Dr. Lashkari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2003 - 2006
David Geffen School of Medicine at UCLAClass of 2003
Certifications & Licensure
CA State Medical License 2005 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
- Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsPhase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.George Somlo, Ashkan Lashkari, William T. Bellamy, Todd M. Zimmerman, Joseph Tuscano
British Journal of Haematology. 2011-08-01 - 14 citationsTandem High-dose Chemotherapy Followed by Autologous Transplantation in Patients with Locally Advanced or Metastatic SarcomaAshkan Lashkari, Warren Chow, Frances Valdes, Lucille Leong, V. U. Phan
Anticancer Research. 2009-08-01 - 10 citationsLong-term Outcome of Autologous Transplantation of Peripheral Blood Progenitor Cells as Postremission Management of Patients ≥60 Years with Acute Myelogenous LeukemiaAshkan Lashkari, Tom Lowe, Eric A. Collisson, Ronald Paquette, Christos Emmanouilides
Biology of Blood and Marrow Transplantation. 2006-04-01
Other Languages
- Farsi, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
